Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Simtra BioPharma Invests $250 Million in Bloomington Sterile Fill/Finish Site
Simtra BioPharma Solutions, recently acquired by Advent International and Warburg Pincus, is expanding its sterile fillfinish manufacturing campus in Bloomington, Indiana
The Ground breaking Commencement of Lek's $400M Biopharmaceutical Production Center Project in Lendava
Initiation of construction for Leks advanced biopharmaceutical production center in Lendava is underway The construction will occur on Leks existing site in Lendava and involves three planned facilities
BioNTech's $150M Investment Propels Rwanda toward mRNA Vaccine Manufacturing Hub
BioNTech SE reaches a significant milestone with the inauguration of its mRNA vaccine manufacturing site in Kigali, Rwanda The site includes the establishment of the first manufacturing
Novo Nordisk Initiates Groundbreaking 16 Billion Danish Kroner Investment for State-of-the-Art Expansion in France
The expansion is geared towards enhancing production capabilities for the current and future portfolio focused on serious chronic diseases
Novo Nordisk Invests Over 42 Billion Danish Kroner in Expanding Manufacturing Facilities in Kalundborg
Novo Nordisk plans to invest more than 42 billion Danish kroner starting in 2023 The investment is focused on expanding existing manufacturing facilities in Kalundborg, Denmark
Gerresheimer Initiates Groundbreaking for New Facility in Querétaro, Supported by a $109.28 Million (100 Million Euro) Investment
The expansion focuses on increasing production capacities for readytofill RTF syringes for the North American market
Almac Group's Groundbreaking £80 Million Expansion Investment in Northern Ireland
The Almac Group has unveiled an 80 million investment program to construct new manufacturing, production, and diagnostic laboratory facilities at its Global Headquarters in Craigavon, Northern Ireland
HERMES PHARMA Unveils Groundbreaking €25 Million Investment to Revolutionize Production Capacity
HERMES PHARMA, a prominent authority in userfriendly oral dosage forms, is enhancing its manufacturing capabilities to meet growing demand for userfriendly oral dosage form development and production
Rising Pharmaceuticals Opens New Facility to Expand Sterile Dosage Capabilities in Illinois, USA
Rising Pharmaceuticals has opened a stateoftheart commercial manufacturing facility in Decatur, Illinois, USA
HERMES PHARMA Invests US$26 milion (€25 million) for Manufacturing Site in Wolfratshausen, Germany
HERMES PHARMA plans to invest US$26 milion 25 million to construct userfriendly oral dosage development and manufacturing site in Wolfratshausen, Germany
